- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 213/82 - AmidesImides in position 3
Patent holdings for IPC class C07D 213/82
Total number of patents in this class: 1067
10-year publication summary
|
93
|
90
|
70
|
68
|
52
|
63
|
50
|
59
|
62
|
49
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4824 |
25 |
| Takeda Pharmaceutical Company Limited | 2716 |
24 |
| F. Hoffmann-La Roche AG | 7934 |
21 |
| Vertex Pharmaceuticals Incorporated | 1621 |
19 |
| Novartis AG | 10626 |
18 |
| Boehringer Ingelheim International GmbH | 4637 |
18 |
| Syngenta Participations AG | 1742 |
17 |
| Amgen Inc. | 4163 |
17 |
| The Johns Hopkins University | 5752 |
16 |
| BASF SE | 21072 |
14 |
| Janssen Pharmaceutica N.V. | 3350 |
12 |
| Syngenta Crop Protection AG | 6236 |
11 |
| Bayer Cropscience AG | 1991 |
11 |
| AstraZeneca AB | 2851 |
10 |
| Sumitomo Chemical Company, Limited | 9110 |
9 |
| Mitsui Chemicals Crop & Life Solutions,Inc. | 164 |
9 |
| Genentech, Inc. | 4008 |
8 |
| The General Hospital Corporation | 4797 |
8 |
| Astellas Pharma Inc. | 1053 |
8 |
| Daiichi Sankyo Company, Limited | 1880 |
8 |
| Other owners | 784 |